Last reviewed · How we verify
NCT04474015: TES
Optimizing Volunteer Comfort for Transcranial Electrical Stimulation (TES): An Assessment
NA trial testing transcranial electric stimulation in Performance Enhancing Product Use in 75 participants. Enrolling by invitation.
12 February 2029
Quick facts
| Lead sponsor | U.S. Army Medical Research and Development Command |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 75 |
| Start date | 24 May 2014 |
| Primary completion | 12 February 2029 |
| Estimated completion | 12 February 2029 |
Drugs / interventions tested
- transcranial electric stimulation
Conditions studied
- Performance Enhancing Product Use — all drugs for Performance Enhancing Product Use →
- Sleep — all drugs for Sleep →
Sponsor
U.S. Army Medical Research and Development Command
Who can join
Adults 18 to 39, any sex, with Performance Enhancing Product Use or Sleep. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Transcranial electrical stimulation (TES) utilizing weak electrical fields (\<5 milliamps of current - as proposed in the present pilot study) is an extremely safe therapeutic technique in use for over 40 years. During that time, TES has never been associated with a serious adverse event in a research setting nor a serious reported adverse event in a clinical setting. The main side effect associated with TES is irritation of the skin beneath the electrodes (as is commonly found from similar preparations used for polysomnography). The purpose of this pilot study is to identify the type of electrode preparation that maximizes subject comfort during transdermal/transcranial electrical stimulation (TES) using the NeuroConn DC Plus Stimulator.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04474015
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of transcranial electric stimulation
Trials testing the same drug.
- NCT06822283 — Plasticity of Deep Brain Structures in Mild Cognitive Impairment and Healthy Aging · NA · completed
- NCT04897633 — Modulation of Cognitive Control Via Transcranial Continuous Electrical Stimulation of Additional Motor Areas in Parkinso · NA · completed
- NCT07092839 — Non-invasive Deep Brain Stimulation to Enhance Motor Skill Acquisition in Individuals With Mild Cognitive Impairment · NA · completed
Other recruiting trials for Performance Enhancing Product Use
Currently open trials in the same condition.
- NCT07412951 — Effects of Caffeine and Shot Put Performance · NA · active not recruiting
- NCT06639789 — Effect of a New Formulation of Vitamin B12 on Physical and Mental · NA · recruiting
- NCT04273776 — A Comparison of the Physiological and Behavioral Effects of Suvorexant and Zolpidem in Healthy Volunteers: A Randomized, · EARLY_PHASE1 · active not recruiting
Other U.S. Army Medical Research and Development Command trials
Trials by the same sponsor.
- NCT05423418 — Safety, Tolerability, and Immunogenicity of ALFQ in a HIV Vaccine Containing A244 and B.65321 in Healthy Adults · Phase 1 · completed
- NCT05348993 — Single or Repeat Dose of G03-52-01 in Adult Subjects · Phase 2 · completed
- NCT04658667 — HIV Vaccine in HIV-uninfected Adults · Phase 1 · completed
- NCT04333459 — Safety and Immunogenicity of a Hantaan Virus DNA Vaccine and a Puumala Virus DNA Vaccine, For The Prevention of Hemorrha · Phase 2 · unknown
- NCT03867162 — FY15-14: Tularemia Vaccine Protocol (NDBR Lot 4) · Phase 2 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04474015 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by U.S. Army Medical Research and Development Command
- Last refreshed: 28 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04474015.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing